Skip to main content
. 2019 Aug 2;11(8):1106. doi: 10.3390/cancers11081106

Figure 3.

Figure 3

Association between HLA-GEV levels with clinical parameters in EOC patients. (A,B) Levels of HLA-GEV are elevated in both patients with MUC and EpCAM positive CTC, compared to patients carrying MUC or EpCAM negative CTC. Given is the median [range] in ng/mL. Statistical significance was tested by Mann–Whitney test, p < 0.05. (C) HLA-GEV levels were higher in EOC patients with a residual tumor burden compared to patients without a detectable residual tumor. Statistical significance was tested by Mann–Whitney test, p < 0.05.